• Profile
Close

Outcome of patients with chronic obstructive pulmonary disease and severe coronary artery disease who had a coronary artery bypass graft or a percutaneous coronary intervention

European Journal of Cardio-Thoracic Surgery Oct 27, 2017

Andell P, et al. - Researchers sought to assess outcome of patients with chronic obstructive pulmonary disease and severe coronary artery disease who had a coronary artery bypass graft or a percutaneous coronary intervention. Findings revealed that these patients were at higher risk of long-term and short-term death and postoperative infections. They recommended considering preventive measures, including careful monitoring for signs of infection and prompt antibiotic treatment when indicated.

Methods

  • From 2006 to 2014, researchers identified patients presenting with acute coronary syndromes with an angiogram showing 3-vessel disease or left main coronary artery involvement who were treated with CABG or percutaneous coronary intervention (PCI) only from the nationwide SWEDEHEART registry.
  • Patients were divided in accordance to COPD status and compared with regard to outcome.
  • For this study, the primary end-point was the 5-year mortality rate; secondary outcomes were the 30-day mortality rate and in-hospital complications after CABG.

Results

  • In the population, researchers identified 6985 patients who had CABG (COPD prevalence = 8.0%) and 14 209 who had PCI only (COPD = 8.2%).
  • Compared to patients without COPD, patients with COPD were older and had more comorbidities.
  • In patients with COPD, the 5-year mortality rate was nearly doubled when compared to patients without COPD (CABG: 27.2% vs 14.5%, P < 0.001; PCI only: 50.1% vs 29.1%, P < 0.001).
  • Patients with COPD in both CABG-treated [hazard ratio = 1.52 (1.25–1.86), P < 0.001] and PCI-treated populations indicated significantly higher 5-year mortality rate even after adjusting for age, sex and comorbidities.
  • In addition, COPD seemed independently associated with markedly more postoperative infections in need of antibiotics [odds ratio = 1.48 (1.07–2.04), P = 0.017] and pneumonia [odds ratio = 2.21 (1.39–3.52), P = 0.001].

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay